Phase II Trial of Temozolomide in Low-Grade Non-Hodgkin's Lymphoma

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.1995.299
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

A Phase II Trial of Adjuvant Low-Dose Total Body Irradiation in Non-Hodgkin's Lymphoma Patients Following Standard CHOP

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2004English

Phase II Trial of Conformal Radiation Therapy for Pediatric Low-Grade Glioma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2009English

Liquid Biopsy in Non‐Hodgkin's Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

The Epidemiology of Non-Hodgkin's Lymphoma

Oncogene
Cancer ResearchGeneticsMolecular Biology
2004English

Fulminant Hepatic Failure in Non-Hodgkin's Lymphoma

Postgraduate Medical Journal
Medicine
1982English

A Critical Analysis of Prognostic Factors for Survival in Intermediate and High Grade Non-Hodgkin's Lymphoma

British Journal of Cancer
Cancer ResearchOncology
1991English

Phase I to III Trials of Anti-B Cell Therapy in Non-Hodgkin's Lymphoma

Clinical Cancer Research
Cancer ResearchOncology
2007English

Temozolomide and Reirradiation in Recurrent Grade II Brain Glioma

World Journal of Oncology
Cancer ResearchOncology
2014English

Classification of Non‐Hodgkin's Lymphoma: A Proposal

Oncologist
Cancer ResearchMedicineOncology
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy